Home telerehabilitation therapy for patients with vascular dementia
Home Tele Rehabilitation Therapy for Vascular Dementia
This study is testing whether home telerehabilitation therapy can help stroke patients with and without vascular dementia improve their arm strength and reduce the stress on their caregivers.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 110 Years |
| Sex | All |
| Sponsor | The Methodist Hospital Research Institute Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06289569 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility and effectiveness of home telerehabilitation therapy for chronic stroke patients with and without vascular dementia. Participants will receive usual care for one month, followed by a month of remote rehabilitation targeting their weaker arm. The study will assess the impact of this intervention on caregiver burden and patient outcomes through various evaluations and questionnaires. Participants will be monitored for safety and comfort throughout the study.
Who should consider this trial
Good fit: Ideal candidates include chronic stroke patients at least 6 months post-stroke with some active movement in their affected upper extremity.
Not a fit: Patients with a history of severe alcohol or drug abuse may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce caregiver burden and improve rehabilitation outcomes for patients with vascular dementia.
How similar studies have performed: Other studies have shown promise in using telerehabilitation for stroke recovery, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Symptomatic ischemic or hemorrhagic stroke verified by computerized axial tomography or magnetic resonance imaging * at least 6 months post stroke * At least some active movement in the affected upper extremity (MRS 1 or more in shoulder elbow or wrist) * Ability to provide informed consent, or LAR able to provide consent * Expressed willingness to comply with all study procedures and attend all study-related visits for both the patient and at least one caregiver. * Age ≥ 18. * Ability to follow one-step commands. * Community-dwelling with transportation to evaluation sessions. * Ability to operate the therapy system with minimal assistance, including sufficient corrected vision to perceive objects from a distance of 5 feet. * Modified Ashworth Scale Score 3 or less in the involved upper extremity * Passive range of motion within functional ranges at the shoulder, elbow, wrist and hand Exclusion Criteria: * Patients with history of severe alcohol or drug abuse, psychiatric illnesses like severe depression, poor motivational capacity, or severe language disturbances, particularly of receptive nature or with serious cognitive deficits (defined as unable to follow study instructions even with help from caregiver). * Patients with bilateral paresis, or weakness or sensory damage due to peripheral causes (e.g. peripheral nerve injury, muscle or orthopedic injury etc.) * Patients with severe uncontrolled medical problems that would render intensive rehabilitation unfeasible or unsafe (e.g. cardiovascular disease, unstable cardiac arrhythmia, severe rheumatoid arthritis, active joint deformity of arthritic origin, active cancer or renal disease, any kind of end-stage pulmonary or cardiovascular disease, or a deteriorated condition due to age, epilepsy or others). * Concurrent participation in other experimental upper extremity rehabilitation trials that would interfere with results. * Non-English-speaking individuals will only be eligible if they can provide the appropriate translator for all the sessions of the study as no funding is available to pay for such services. However, we plan to include them once funding has been secured in the subsequent larger trial. * Pregnancy * Prisoners
Where this trial is running
Houston, Texas
- Houston Methodist Hospital — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Timea Hodics, MD — The Methodist Hospital Research Institute
- Study coordinator: Darrel W Cleere, MPH
- Email: dwcleere@houstonmethodist.org
- Phone: (713)-441-3770
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.